5505 studies found for:    vaccination
Show Display Options
Rank Status Study
1 Completed Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine
Condition: Influenza
Interventions: Biological: Vaccination with Fluval P and Fluval AB influenza vaccines;   Biological: Vaccination with Fluval P monovalent influenza vaccine
2 Recruiting Safety Study Of Anakinra Combined With Chemotherapy And Dendritic Cell Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Biological: DC vaccination+Preop chemotherapy;   Biological: DC vaccination+Preop chemo+anakinra
3 Completed Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant
Condition: Influenza
Interventions: Biological: Fluzone vaccine with JVRS-100 adjuvant;   Biological: Fluzone vaccine
4 Completed Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children
Condition: Influenza
Intervention: Biological: Vaccination with FLUVAL P
5 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
6 Completed Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons
Condition: Influenza
Intervention: Biological: Vaccination with Fluval AB influenza vaccine
7 Completed Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination
Condition: Cystic Fibrosis With Gastrointestinal Manifestation
Intervention: Biological: influenza vaccination
8 Terminated Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
Condition: Malignant Melanoma Stage IV
Interventions: Biological: DC Vaccine & Cyclophosphamide;   Biological: DC Vaccine & Placebo
9 Withdrawn Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
Condition: Influenza
Interventions: Biological: Vaccine Sanofi A(H1N1) 15 ug & trivalent;   Biological: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante;   Biological: Vaccine Sanofi A(H1N1) 7.5 ug
10 Active, not recruiting Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
11 Recruiting Multiple Antigen-Engineered DC Vaccine for Melanoma
Condition: Melanoma
Interventions: Biological: DC Vaccine + IFN;   Biological: AdVTMM2/DC Vaccination
12 Active, not recruiting Prospective Trial of Vaccine Responses in Childhood Cancer Survivors
Conditions: Childhood Cancer;   Multiple Diseases
Interventions: Biological: Immunization Schedule patients <7 years.;   Biological: Immunization Schedule patients > or = to 7 years and <11 years of age;   Biological: Immunization Schedule patients > or = to 11 years of age
13 Completed School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities
Conditions: Immunizations;   Vaccination;   Influenza;   School Health
Interventions: Behavioral: School based flu vaccine: Low intensity;   Behavioral: School based flu vaccine: High intensity
14 Completed Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines
Condition: Influenza
Interventions: Biological: pandemic vaccine 1;   Biological: pandemic vaccine 2;   Biological: pandemic vaccine 5;   Biological: pandemic vaccine 6;   Biological: pandemic vaccine 9;   Biological: pandemic vaccine 10;   Biological: pandmeic vaccine 11;   Biological: pandmeic vaccine 12;   Biological: pandmic vaccine 13;   Biological: placebo group 14
15 Completed Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Condition: Influenza
Interventions: Biological: Fluzone® Quadrivalent vaccine, 2014-2015 formulation;   Biological: Fluzone I®ntradermal vaccine, 2014-2015 formulation;   Biological: Fluzone High Dose vaccine, 2014-2015 formulation
16 Recruiting Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Condition: Meningitis
Interventions: Biological: MCV-ACYW135 Vaccine Group;   Biological: MPV-ACYW135 Vaccine Group;   Biological: MPV-A Vaccine Group;   Biological: MCV-AC Vaccine Group;   Biological: Hib Vaccine Group
17 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine
18 Completed
Has Results
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: MenACWY-CRM197;   Biological: DTaP (Diptheria, Tetanus, Pertussis) Vaccine;   Biological: Hib (Haemophilus influenza b) Vaccine;   Biological: IPV (Inactivated Polio Vaccine) Vaccine;   Biological: Pneumococcal conjugate Vaccine;   Biological: MMR (Measles, Mumps, and Rubella) Vaccine;   Biological: Varicella Vaccine;   Biological: Hepatitis A Virus
19 Active, not recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination
20 Completed
Has Results
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
Condition: Meningitis, Meningococcal
Interventions: Biological: Meningococcal ACWY Conjugate Vaccine;   Biological: DTaP-IPV-HBV;   Biological: Hib;   Biological: Rotavirus;   Biological: Pneumococcal 7-valent Conjugate Vaccine;   Biological: HAV;   Biological: MMR-V;   Biological: DTaP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years